<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <link rel="stylesheet" href="css/bootstrap.min.css">
  <link rel="stylesheet" type="text/css" href="css/style.css">
  <title>MtSite</title>
</head>
<body>

<div class=" mybackground myjumbotron mb-0" id="jumbotron">
  <div class="mycontainer">
    <h1>Akt/PKB signaling pathway</h1>
    <p>Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.</p>
  </div>
</div>

<nav class="nav navbar navbar-dark navbar-fixed-top navbar-expand-md" style="background-color: #032C4D">
    <button class="navbar-toggler" type="button" 
      data-toggle="collapse" data-target="#myTogglerNav"
      aria-controls="myTogglerNav"
      aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div class="collapse navbar-collapse" id="myTogglerNav">
    <div class="navbar-nav ml-auto">
        <a class="nav-item nav-link active" href="index.html">Home</a>

        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown1" aria-haspopup="true" aria-expended="false" href="#">My Interests</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown1">
              <a class="dropdown-item" href="#">Bootstrap</a>
              <a class="dropdown-item" href="#">Sass</a>
              <a class="dropdown-item" href="#">Node JS</a>
            </div>
        </div><!-- cdropdown -->
        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown2" aria-haspopup="true" aria-expended="false" href="#">Drug Discovery</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown2">
              <a class="dropdown-item" href="protin_kinase.html">Protein Kinase</a>
              <a class="dropdown-item" href="AKT_PKB_signaling.html">Akt/PKB signaling pathway</a>
              <a class="dropdown-item" href="mTOR_inhibitors.html">mTOR inhibitors</a>
			  <a class="dropdown-item" href="analgesics.html">Analgesics</a>
			  <a class="dropdown-item" href="G_protein_coupled_receptor.html">GPCRs</a>
            </div>
        </div><!-- cdropdown -->
        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown3" aria-haspopup="true" aria-expended="false" href="#">Photography</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown3">
              <a class="dropdown-item" href="#">Mission1</a>
              <a class="dropdown-item" href="#">Mission2</a>
              <a class="dropdown-item" href="#">Mission3</a>
            </div>
        </div><!-- cdropdown -->
      <a class="nav-item nav-link" href="#">Testimonials</a>
    </div><!-- navbar nav-->
    </div><!-- collapse-->
</nav>	

<div class="container-fluid">
	<div class="row">  
	<div class="col-md-2 bg-success">
	
    </div><!-- col-2 -->
		
	<div class="col-md-8">
		<section class="text-justify">
   <div class="panel panel-default">
   <div class="panel-body">
   <h1>Akt/PKB  signaling pathway</h1>
    <p>The Akt Pathway, or PI3K-Akt  Pathway is a <a href="https://en.wikipedia.org/wiki/Signal_transduction" title="Signal transduction">signal  transduction</a> pathway that  promotes survival and growth in response to extracellular signals. Key proteins  involved are PI3K (<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_3-kinase" title="Phosphatidylinositol 3-kinase">phosphatidylinositol 3-kinase</a>) and Akt (<a href="https://en.wikipedia.org/wiki/Protein_Kinase_B" title="Protein Kinase B">Protein  Kinase B</a>). Initial  stimulation by one of the growth factors causes activation of a cell surface  receptor and <a href="https://en.wikipedia.org/wiki/Phosphorylation" title="Phosphorylation">phosphorylation</a> of PI3K. Activated PI3K then  phosphorylates lipids on the plasma membrane, forming <a href="https://en.wikipedia.org/wiki/Second_messenger" title="Second messenger">second messenger</a> <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4,5)-trisphosphate" title="Phosphatidylinositol (3,4,5)-trisphosphate">phosphatidylinositol (3,4,5)-trisphosphate</a> (PIP3). Akt, a <a href="https://en.wikipedia.org/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">serine/threonine kinase</a>, is recruited to the membrane by interaction with  these phosphoinositide docking sites, so that it can be fully activated.<a href="https://en.wikipedia.org/wiki/Akt/PKB_signaling_pathway#cite_note-Osaki2004-1"></a> Activated Akt mediates downstream responses,  including cell survival, growth, <a href="https://en.wikipedia.org/wiki/Cell_proliferation" title="Cell proliferation">proliferation</a>, <a href="https://en.wikipedia.org/wiki/Cell_migration" title="Cell migration">cell migration</a> and <a href="https://en.wikipedia.org/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a>, by phosphorylating a range of intracellular  proteins. The pathway is present in all cells of higher <a href="https://en.wikipedia.org/wiki/Eukaryotes" title="Eukaryotes">eukaryotes</a> and is highly conserved.<a href="https://en.wikipedia.org/wiki/Akt/PKB_signaling_pathway#cite_note-Manning2007-2"></a> The pathway is highly regulated by multiple  mechanisms, often involving cross-talk with other signalling pathways. Problems  with PI3K-Akt pathway regulation can lead to increase in signalling activity.  This has been linked to a range of diseases such as <a href="https://en.wikipedia.org/wiki/Cancer" title="Cancer">cancer</a> and <a href="https://en.wikipedia.org/wiki/Type_II_diabetes" title="Type II diabetes">type II  diabetes</a>. A major  antagonist of PI3K activity is <a href="https://en.wikipedia.org/wiki/PTEN_(gene)" title="PTEN (gene)">PTEN</a> (phosphatase and tensin homolog), a tumour  suppressor which is often mutated or lost in cancer cells. Akt phosphorylates  as many as 100 different substrates, leading to a wide range of effects on  cells.</p>
   </div>
   </div>
   
   <h2>1.0  Mechanism</h2>
   <h3>1.1  PI3K Activation</h3>
   <p><img src="images/img/P13K-Akt_Pathway_Activated_by_RTK.png" alt="Akt_Pathway_Activated_by_RTK" width="760" height="326" class="img-responsive" border="0" style="float: left; margin-bottom: 10px; margin-right: 20px">There are multiple types of<a href="https://en.wikipedia.org/wiki/Phosphoinositide_3-kinase" title="Phosphoinositide 3-kinase"> phosphoinositide  3-kinase</a> but only class I  are responsible for lipid phosphorylation in response to growth stimuli. Class  1 PI3Ks are heterodimers composed of a regulatory <a href="https://en.wikipedia.org/wiki/Protein_subunit" title="Protein subunit">subunit</a> p85 and a catalytic subunit p110, named by their  molecular weights.The pathway can be activated  by a range of signals, including <a href="https://en.wikipedia.org/wiki/Hormones" title="Hormones">hormones</a>, <a href="https://en.wikipedia.org/wiki/Growth_factor" title="Growth factor">growth factors</a> and components of the <a href="https://en.wikipedia.org/wiki/Extracellular_matrix" title="Extracellular matrix">extracellular  matrix</a> (ECM). It is stimulated  by binding of an extracellular ligand to a <a href="https://en.wikipedia.org/wiki/Receptor_tyrosine_kinase" title="Receptor tyrosine kinase">receptor  tyrosine kinase</a> (RTK) in  the plasma membrane, causing receptor dimerization and cross-phosphorylation of  tyrosine residues in the intracellular domains. The regulatory subunit p85  binds to phosphorylated tyrosine residues on the activated receptor via its <a href="https://en.wikipedia.org/wiki/SH2_domain" title="SH2 domain">Src homology 2 (SH2) domain</a>. It then recruits the catalytic subunit  p110 to form the fully active PI3K enzyme. Alternatively, adaptor molecule <a href="https://en.wikipedia.org/wiki/Grb2" title="Grb2">Grb2</a> binds to phospho-YXN motifs of the RTK and recruits p85 via <a href="https://en.wikipedia.org/wiki/GAB1" title="GAB1">Grb2-associated binding</a> (GAB) scaffold protein. The p110 subunit can also  be recruited independently of p85. For example, Grb2 can also bind the Ras-GEF  Sos1, leading to activation of <a href="https://en.wikipedia.org/wiki/Ras_protein" title="Ras protein">Ras</a>. Ras-GTP then activates the p110 subunit of PI3K.  Other adaptor molecules such as <a href="https://en.wikipedia.org/wiki/Insulin_receptor_substrate" title="Insulin receptor substrate">insulin  receptor substrate</a> (IRS)  can also activate p110. PI3K can also be activated  by <a href="https://en.wikipedia.org/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">G  protein-coupled receptors</a> (GPCR), via G-protein βγ dimers or Ras which bind PI3K directly. In  addition, the Gα subunit activates Src-dependent <a href="https://en.wikipedia.org/wiki/Integrin" title="Integrin">integrin</a> signalling which can activate PI3K. </p>
   
   <h3>1.2  Phosphoinositide Formation</h3>
   <p><img src="images/img/Phosphoinositol_3,4,5-Trisphosphate.png" alt="Akt_Pathway_Activated_by_RTK" width="300" height="295" class="img-responsive" border="0" style="float: left; margin-bottom: 10px; margin-right: 20px">Activated PI3K catalyses the  addition of phosphate groups to the 3'-OH position the inositol ring of <a href="https://en.wikipedia.org/wiki/Phosphoinositide" title="Phosphoinositide">phosphoinositides</a> (PtdIns), producing three lipid products, PI(3)P,  PI(3,4)P2 and PI(3,4,5)P3:<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol" title="Phosphatidylinositol">Phosphatidylinositol</a> (PI) → <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_3-phosphate" title="Phosphatidylinositol 3-phosphate">PI 3-phosphate</a>,  (PI(4)P) → <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_3,4-bisphosphate" title="Phosphatidylinositol 3,4-bisphosphate">PI 3,4-bisphosphate</a>, (PI(4,5)P2)  → <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4,5)-trisphosphate" title="Phosphatidylinositol (3,4,5)-trisphosphate">PI 3,4,5-triphosphate</a>These phosphorylated lipids  are anchored to the plasma membrane, where they can directly bind intracellular  proteins containing a <a href="https://en.wikipedia.org/wiki/Pleckstrin_homology" title="Pleckstrin homology">pleckstrin  homology</a> (PH) or <a href="https://en.wikipedia.org/wiki/FYVE_domain" title="FYVE domain">FYVE</a> domain. For example, the triphosphate form  (PI(3,4,5)P3) binds Akt and <a href="https://en.wikipedia.org/wiki/Phosphoinositide-dependent_kinase-1" title="Phosphoinositide-dependent kinase-1">phosphoinositide-dependent kinase 1</a> (PDK1) so they accumulate in close proximity at  the membrane. </p>
   
   <h3>1.3  Akt Activation</h3>
   <p>Akt resides in the cytosol  in an inactive conformation, until the cell is stimulated and it translocates  to the plasma membrane. The Akt PH domain has a high affinity for second  messenger PI(3,4,5)P3, binding to it preferentially over other  phosphoinositides. Thus PI3K activity is essential for translocation of Akt to  the membrane. Interaction with <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4,5)-trisphosphate" title="Phosphatidylinositol (3,4,5)-trisphosphate">PI(3,4,5)P3</a> causes <a href="https://en.wikipedia.org/wiki/Conformational_change" title="Conformational change">conformational  changes</a> and exposure of  phosphorylation sites Thr308 in the kinase domain and Ser473 in the C-terminal  domain. Akt is partially activated by phosphorylation of T308 by PDK1. Full  activation requires phosphorylation of S473, which can be catalysed by multiple  proteins, including phosphoinositide-dependent kinase 2 (PDK2), <a href="https://en.wikipedia.org/wiki/Integrin-linked_kinase" title="Integrin-linked kinase">integrin-linked  kinase</a> (ILK), <a href="https://en.wikipedia.org/wiki/Mechanistic_target_of_rapamycin" title="Mechanistic target of rapamycin">mechanistic target of rapamycin complex</a> (mTORC) and <a href="https://en.wikipedia.org/wiki/DNA-PKcs" title="DNA-PKcs">DNA-dependent protein kinase</a> (DNA-PK). The regulation of Ser473  phosphorylation is not fully understood but may also be influenced by  autophosphorylation after Thr308 phosphorylation. After stimulation, the levels  of PIP3 decrease and Akt activity is attenuated by dephosphorylation  by serine/threonine <a href="https://en.wikipedia.org/wiki/Phosphatase" title="Phosphatase">phosphatases</a>.</p>
   <h3>1.4  PI3K-Independent Activation. </h3>
   <p>Although PI3K is the major  mode of Akt activation, other tyrosine or serine/threonine kinases have been  shown to activate Akt directly, in response to growth factors, inflammation or  DNA damage. These can function even when PI3K activity is inhibited. Other  studies have shown Akt can be activated in response to <a href="https://en.wikipedia.org/wiki/Heat_shock" title="Heat shock">heat shock</a> or increases in cellular <a href="https://en.wikipedia.org/wiki/Calcium_in_biology" title="Calcium in biology">Ca2+</a> concentration, via Ca2+/Calmodulin-dependent  protein kinase kinase (<a href="https://en.wikipedia.org/wiki/CAMKK2" title="CAMKK2">CAMKK</a>).</p>
   <table class="mytable" border="1" cellpadding="0" width="95%">
     <tr>
       <td width="30%"><p>Activating Kinase</p></td>
       <td width="22%"><p>Akt Phosphorylation Site</p></td>
       <td width="48%"><p>Details</p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/TNK2" title="TNK2">Activated    CDC42 kinase 1 (Ack1)</a></p></td>
       <td><p>Tyr176</p></td>
       <td><p>Akt binds preferentially to <a href="https://en.wikipedia.org/wiki/Phosphatidic_acid" title="Phosphatidic acid">phosphatidic acid</a> (PA) instead of PIP3    allowing translocation to the plasma membrane.</p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/Proto-oncogene_tyrosine-protein_kinase_Src" title="Proto-oncogene tyrosine-protein kinase Src">Src</a></p></td>
       <td><p>Tyr315, Tyr326</p></td>
       <td><p>Requires interaction of the Src <a href="https://en.wikipedia.org/wiki/SH3_domain" title="SH3 domain">SH3 domain</a> and proline-rich region at the C-terminal of Akt.</p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/PTK6" title="PTK6">Protein    tyrosine kinase 6</a> (PTK6)</p></td>
       <td><p>Tyr215, Tyr315 and Tyr326</p></td>
       <td><p>Activates Akt in response to <a href="https://en.wikipedia.org/wiki/Epidermal_growth_factor" title="Epidermal growth factor">epidermal growth factor</a> (EGF)</p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/I%CE%BAB_kinase" title="IκB kinase">IκB kinase ε</a> (IKKε)</p></td>
       <td><p>Ser137, Thr308 and Ser473</p></td>
       <td><p>Independent of the PH domain, PI3K, PDK1 and mTOR </p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/TANK-binding_kinase_1" title="TANK-binding kinase 1">TANK-binding kinase 1</a> (TBK1)</p></td>
       <td><p>Thr195, Ser378 and Ser473</p></td>
       <td><p>In response to <a href="https://en.wikipedia.org/wiki/Toll-like_receptor" title="Toll-like receptor">Toll-like receptor</a> activation in macrophages.</p></td>
     </tr>
     <tr>
       <td><p><a href="https://en.wikipedia.org/wiki/DNA-PKcs" title="DNA-PKcs">DNA-dependent    protein kinase</a> (DNA-PK)</p></td>
       <td><p>Ser473</p></td>
       <td><p>Activated by double-strand DNA breaks formed by ionizing radiation.</p></td>
     </tr>
   </table>
   
   <h2>2.0  Regulation</h2>
   <p><img src="images/img/Regulation_of_P13K-Akt_Pathway_in_Feedback_Loops.png" alt="Regulation_of_P13K-Akt_Pathway_in_Feedback_Loops.png" width="450" height="408" class="img-responsive" border="0" style="float: left; margin-bottom: 10px; margin-right: 20px;">The PI3K-Akt pathway has  many downstream effects and must be carefully regulated. One of the ways the  pathway is negatively regulated is by reducing PIP3 levels. <a href="https://en.wikipedia.org/wiki/PTEN_(gene)" title="PTEN (gene)">Phosphatase and tensin homolog</a> (PTEN) antagonises PI3K by converting  PI(3,4,5)P3 into PI(4,5)P2. Loss of PTEN function leads  to over-activation of Akt and is common in cancer cells (PTEN is a <a href="https://en.wikipedia.org/wiki/Tumour_suppressor_gene" title="Tumour suppressor gene">tumour  suppressor</a>). <a href="https://en.wikipedia.org/wiki/SHIP1" title="SHIP1">SH2-containing Inositol Phosphatase</a> (SHIP) also dephosphorylates PI(3,4,5)P3,  at the 5' position of the inositol ring.<a href="https://en.wikipedia.org/wiki/Akt/PKB_signaling_pathway#cite_note-Georgescu2010-22">[22]</a> The PI3K-Akt pathway regulates PTEN levels by  affecting its transcription and activity. Transcription factor <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a>, activated by Akt, regulates <a href="https://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor_delta" title="Peroxisome proliferator-activated receptor delta">peroxisome proliferator-activated receptor delta</a> (PPARβ/δ) agonists and <a href="https://en.wikipedia.org/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha">tumour necrosis factor α</a> (TNFα), which in turn repress PTEN expression. NEDD4-1, an E3 ligase that  recognises PTEN for degradation is up-regulated by the PI3K pathway. Therefore,  when Akt is activated, PTEN is further repressed in a <a href="https://en.wikipedia.org/wiki/Positive_feedback" title="Positive feedback">positive feedback</a> loop. The pathway is also  controlled by <a href="https://en.wikipedia.org/wiki/Protein_phosphatase_2" title="Protein phosphatase 2">protein  phosphatase 2A</a> (PP2A),  which dephosphorylates Akt at Thr308 and phosphatase <a href="https://en.wikipedia.org/wiki/PHLPP" title="PHLPP">PHLPP</a> dephosphorylates Akt at Ser473. Another protein important in Akt  attenuation is Carboxy Terminal Modulator Protein (CTMP). CTMP binds to the  regulatory domain of Akt, blocking its phosphorylation and activation. When the pathway is  activated by <a href="https://en.wikipedia.org/wiki/Insulin" title="Insulin">insulin</a>, <a href="https://en.wikipedia.org/wiki/IRS1" title="IRS1">insulin receptor substrate 1</a> (IRS-1) transcription is down-regulated,  in a <a href="https://en.wikipedia.org/wiki/Negative_feedback" title="Negative feedback">negative  feedback</a> loop via mTORC1  and S6K1 activation. S6K1 is also able to phosphorylate IRS-1 at multiple  serine residues, preventing binding to RTKs. Another negative feedback control  mechanism regulating the pathway involves <a href="https://en.wikipedia.org/wiki/FOX_proteins" title="FOX proteins">FoxO transcription factors</a>. Activated Akt causes FoxO degradation,  so it can no longer inhibit PP2A, thus leading to a decrease in Akt  phosphorylation.</p>
   
   <h2>3.0  Downstream Effects</h2>
   <p>Once active, Akt  translocates from the plasma membrane to the <a href="https://en.wikipedia.org/wiki/Cytosol" title="Cytosol">cytosol</a> and <a href="https://en.wikipedia.org/wiki/Cell_nucleus" title="Cell nucleus">nucleus</a>, where many of its substrates reside. Akt  regulates a wide range of proteins by phosphorylation. Akt target substrates  contain a minimum <a href="https://en.wikipedia.org/wiki/Consensus_sequence" title="Consensus sequence">consensus  sequence</a> R-X-R-X-X-[Ser/Thr]-Hyd, where Hyd is a hydrophobic <a href="https://en.wikipedia.org/wiki/Amino_acid" title="Amino acid">amino acid</a>, although other factors such as sub-cellular  localisation and 3-dimensional structure are important. Phosphorylation by Akt  can be inhibitory or stimulatory, either suppressing or enhancing the activity  of target proteins.</p>
   
   <h3>3.1  Cell Survival and Apoptosis</h3>
   <p><img src="../images/img/Akt_Phosphorylation_Substrates_Affecting_Apoptosis.png" alt="Akt_Phosphorylation_Substrates_Affecting_Apoptosis" width="760" class="img-responsive" border="0" style="float: left; margin-bottom: 10px; margin-right: 20px;">The Akt-PI3K pathway is  essential for cell survival as activated Akt influences many factors involved  in <a href="https://en.wikipedia.org/wiki/Apoptosis" title="Apoptosis">apoptosis</a>, either by <a href="https://en.wikipedia.org/wiki/Transcription_(genetics)" title="Transcription (genetics)">transcription</a> regulation or direct  phosphorylation.  In the nucleus, Akt  inhibits transcription factors that promote the expression of cell death genes,  and enhances transcription of anti-apoptotic genes. A well studied example is  the <a href="https://en.wikipedia.org/wiki/FOX_proteins" title="FOX proteins">Forkhead family  transcription factors</a> (FoxO/FH), of which <a href="https://en.wikipedia.org/wiki/FOXO1" title="FOXO1">FKHR/FoxO1</a>, <a href="https://en.wikipedia.org/wiki/FOXO3" title="FOXO3">FKHRL1/FoxO3</a> and <a href="https://en.wikipedia.org/wiki/FOXO4" title="FOXO4">AFX/FoxO4</a> are directly phosphorylated by Akt. This  phosphorylation induces export to the cytosol where they are sequestered by <a href="https://en.wikipedia.org/wiki/14-3-3_protein" title="14-3-3 protein">14-3-3 proteins</a> and eventually undergo degradation via the <a href="https://en.wikipedia.org/wiki/Proteasome" title="Proteasome">ubiquitin-proteasome</a> pathway. Akt also positively regulates  some transcription factors to allow expression of pro-survival genes. Akt can  phosphorylate and activate the <a href="https://en.wikipedia.org/wiki/I%CE%BAB_kinase" title="IκB kinase">IκB kinase</a> IKKα, causing degradation of <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB#Inhibition" title="NF-κB">IκB</a> and nuclear translocation of <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a> where it promotes expression of caspase inhibitors, <a href="https://en.wikipedia.org/wiki/MYB_(gene)" title="MYB (gene)">c-Myb</a> and <a href="https://en.wikipedia.org/wiki/Bcl-xL" title="Bcl-xL">Bcl-xL</a>. Also promoting cell survival, <a href="https://en.wikipedia.org/wiki/CREB" title="CREB">cAMP response element binding protein</a> (CREB) is phosphorylated by Akt at  Ser133, stimulating recruitment of <a href="https://en.wikipedia.org/wiki/CREB-binding_protein" title="CREB-binding protein">CREB-binding  protein</a> (CBP) to the  promoter of target genes, such as <a href="https://en.wikipedia.org/wiki/Bcl-2" title="Bcl-2">Bcl-2</a>. Akt has also been shown to phosphorylate <a href="https://en.wikipedia.org/wiki/Mdm2" title="Mdm2">murine double minute 2</a> (Mdm2), a key regulator of DNA damage responses,  at Ser166 and Ser186. Phosphorylation of Mdm2 by Akt upregulates its  ubiquitin-ligase activity, therefore indirectly suppressing <a href="https://en.wikipedia.org/wiki/P53" title="P53">p53</a>-mediated apoptosis. Another target of Akt is the <a href="https://en.wikipedia.org/wiki/YAP1" title="YAP1">Yes-associated protein</a> (YAP), phosphorylated at Ser127 leading to 14-3-3  binding and cytosolic localisation. Therefore, it cannot co-activate <a href="https://en.wikipedia.org/wiki/P73" title="P73">p73</a>-mediated apoptosis in response to DNA damage. Akt negatively regulates  pro-apoptotic proteins by direct phosphorylation. For example, phosphorylation  of <a href="https://en.wikipedia.org/wiki/Bcl-2-associated_death_promoter" title="Bcl-2-associated death promoter">BAD</a>, the Bcl-2 family  member, on Ser136 causes translocation from the mitochondrial membrane to the  cytosol, where it is sequestered by <a href="https://en.wikipedia.org/wiki/14-3-3_protein" title="14-3-3 protein">14-3-3 proteins</a>. Akt phosphorylates <a href="https://en.wikipedia.org/wiki/Caspase-9" title="Caspase-9">Caspase-9</a> on Ser196, preventing a <a href="https://en.wikipedia.org/wiki/Caspase" title="Caspase">caspase cascade</a> leading to cell death. Akt also  phosphorylates <a href="https://en.wikipedia.org/wiki/MAP_kinase" title="MAP kinase">MAP kinase kinase  kinases</a> (MAPKKK) upstream  of the stress-activated protein kinase (SAPK) pathway. Phosphorylation of <a href="https://en.wikipedia.org/wiki/ASK1" title="ASK1">apoptosis signal-regulating kinase 1</a> (ASK1) on Ser83 and <a href="https://en.wikipedia.org/wiki/MAP3K13" title="MAP3K13">mixed lineage kinase 3</a> (MLK3) on Ser674 inhibits their activity and  prevents MAP kinase induced apoptosis.</p>
   
   <h3>3.2  Lysosome biogenesis and autophagy</h3>
   <p>Akt regulates <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, a master controller of lysosomal biogenesis, by direct  phosphorylation of <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a> at serine 467. Phosphorylated TFEB is  excluded from the nucleus and less active. Pharmacological inhibition of Akt  promotes nuclear translocation of <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, lysosomal biogenesis and autophagy.</p>
   
   <h3>3.3  Cell Cycle Progression</h3>
   <p><img src="../images/img/Akt_Substrates_Involved_in_Cell_Cycle_Regulation.png" alt="Akt_Substrates_Involved_in_Cell_Cycle_Regulation" width="700" class="img-responsive" border="0" style="float: left; margin-bottom: 10px; margin-right: 20px;">Akt promotes G1-S phase <a href="https://en.wikipedia.org/wiki/Cell_cycle" title="Cell cycle">cell cycle</a> progression by phosphorylating and inactivating <a href="https://en.wikipedia.org/wiki/Glycogen_synthase_kinase_3" title="Glycogen synthase kinase 3">glycogen  synthase kinase 3</a> (GSK-3)  at Ser9. This prevents the phosphorylation and degradation of <a href="https://en.wikipedia.org/wiki/Cyclin_D1" title="Cyclin D1">cyclin D1</a>.   Therefore, Akt promotes G1 phase progression in a positive feedback  loop. Akt promotes cyclin D1 translation via indirect activation of <a href="https://en.wikipedia.org/wiki/Mechanistic_target_of_rapamycin" title="Mechanistic target of rapamycin">mTOR</a>. mTOR increases  translation of cyclin D1 by activating ribosomal protein <a href="https://en.wikipedia.org/wiki/Ribosomal_s6_kinase" title="Ribosomal s6 kinase">S6K</a>, and inhibiting <a href="https://en.wikipedia.org/wiki/EIF4EBP1" title="EIF4EBP1">eukaryotic translation initiation factor  4E-binding protein</a> (4E-BP), thus increasing <a href="https://en.wikipedia.org/wiki/EIF4E" title="EIF4E">eIF4e</a> activity. Akt both indirectly and  directly regulates <a href="https://en.wikipedia.org/wiki/Cyclin-dependent_kinase" title="Cyclin-dependent kinase">cyclin-dependent  kinase</a> (CDK) inhibitors <a href="https://en.wikipedia.org/wiki/P21" title="P21">p21</a>Cip1 and <a href="https://en.wikipedia.org/wiki/CDKN1B" title="CDKN1B">p27</a>Kip1 , allowing  cell cycle progression. Akt phosphorylates p27kip1 at Thr157,  preventing its nuclear import. In addition, Akt phosphorylates Thr145 and  Ser146 of p21Cip1, preventing <a href="https://en.wikipedia.org/wiki/PCNA" title="PCNA">PCNA</a> binding and decreasing stability. Akt phosphorylation of <a href="https://en.wikipedia.org/wiki/FOXO" title="FOXO">Foxo</a> transcription factors also affects the cell cycle, as inhibitory  phosphorylation of <a href="https://en.wikipedia.org/wiki/FOXO4" title="FOXO4">FoxO4</a> (also named AFX) prevents p27 gene  expression.</p>
  
   <h3>3.4  Cell Migration</h3>
   <p>Akt phosphorylates many  proteins involved in polymerisation and stabilisation of the <a href="https://en.wikipedia.org/wiki/Actin" title="Actin">actin</a> <a href="https://en.wikipedia.org/wiki/Cytoskeleton" title="Cytoskeleton">cytoskeleton</a>. In normal cells, this can either  increase the stability of cytoskeleton components or promote <a href="https://en.wikipedia.org/wiki/Cell_migration" title="Cell migration">migration</a> via remodelling. Examples are listed below:
   <ul type="disc">
   <li>Actin filaments - Akt phosphorylates actin directly </li><li>Akt phosphorylation enhancer (APE), also named <a href="https://en.wikipedia.org/wiki/Girdin" title="Girdin">girdin</a> - phosphorylated at Ser1416 causing translocation to the leading edge of filaments, essential for migration</li><li><a href="https://en.wikipedia.org/wiki/Sodium%E2%80%93hydrogen_antiporter_1" title="Sodium–hydrogen antiporter 1">Sodium-hydrogen exchanger 1</a> (NHE1) - phosphorylated at Ser648, promoting cytoskeletal rearrangements and migration </li><li><a href="https://en.wikipedia.org/wiki/FLNA" title="FLNA">Filamin A</a> - phosphorylated at Ser2152, promoting <a href="https://en.wikipedia.org/wiki/Caveolin_1" title="Caveolin 1">caveolin-1</a> mediated cell migration </li><li>Kank - kidney ankyrin repeat-containing protein - negatively regulating <a href="https://en.wikipedia.org/wiki/RHOA" title="RHOA">RhoA</a> activation and cell migration in response to insulin and <a href="https://en.wikipedia.org/wiki/Epidermal_growth_factor" title="Epidermal growth factor">EGF</a></li><li><a href="https://en.wikipedia.org/wiki/TSC2" title="TSC2">Tuberous sclerosis complex 2</a> (TSC2) - Akt1 destabilises the Rho GTPase, inhibits <a href="https://en.wikipedia.org/wiki/Actin#F-Actin" title="Actin">F-actin</a> assembly and reduces cell migration </li><li><a href="https://en.wikipedia.org/wiki/Palladin" title="Palladin">Palladin</a>-Akt1 phosphorylates the actin-binding protein at Ser507, disrupting cross-linking of F-actin bundles </li></ul> Akt promotes cell migration  by interacting with other cytoskeleton components. The type III <a href="https://en.wikipedia.org/wiki/Intermediate_filament" title="Intermediate filament">intermediate  filament</a> <a href="https://en.wikipedia.org/wiki/Vimentin" title="Vimentin">Vimentin</a> is phosphorylated by Akt1 at Ser39, preventing its degradation. In normal  cells, this maintains tissue stability. <a href="https://en.wikipedia.org/wiki/SKP2" title="SKP2">S-phase kinase-associated protein 2</a> (Skp2)-Ser72 phosphorylation enhances <a href="https://en.wikipedia.org/wiki/Ubiquitin_ligase" title="Ubiquitin ligase">E3 ligase</a> activity and cytosolic localisation, promoting cell motility. Akt phosphorylates <a href="https://en.wikipedia.org/wiki/GSK3B" title="GSK3B">GSK3 beta</a>, indirectly activating <a href="https://en.wikipedia.org/wiki/Microtubule" title="Microtubule">microtubule</a> binding protein <a href="https://en.wikipedia.org/wiki/Adenomatous_polyposis_coli" title="Adenomatous polyposis coli">adenomatous polyposis coli</a> (APC). <a href="https://en.wikipedia.org/wiki/Endothelial_NOS" title="Endothelial NOS">Endothelial nitric oxide synthase</a> (eNOS) is phosphorylated at Ser1177,  leading to NO synthesis and endothelial cell migration. In addition, the  pro-migratory <a href="https://en.wikipedia.org/wiki/GTPase-activating_protein" title="GTPase-activating protein">GTPase-activating  protein</a> <a href="https://en.wikipedia.org/wiki/Rho_family_of_GTPases" title="Rho family of GTPases">RhoGAP22</a> is phosphorylated at Ser16.</p>
   
   <h3>4.1  Angiogenesis</h3>
   <p><a href="https://en.wikipedia.org/wiki/Angiogenesis" title="Angiogenesis">Angiogenesis</a>, the formation of new blood vessels, is  often critical for tumour cells to survive and grow in nutrient-depleted  conditions. Akt is activated downstream of <a href="https://en.wikipedia.org/wiki/VEGF" title="VEGF">vascular endothelial growth factor</a> (VEGF) in <a href="https://en.wikipedia.org/wiki/Endothelium" title="Endothelium">endothelial cells</a> in the lining of blood vessels, promoting  survival and growth. Akt also contributes to angiogenesis by activating <a href="https://en.wikipedia.org/wiki/Endothelial_NOS" title="Endothelial NOS">endothelial nitric oxide synthase</a> (eNOS), which increases production of <a href="https://en.wikipedia.org/wiki/Nitric_oxide" title="Nitric oxide">nitric oxide</a> (NO). This stimulates vasodilation and vascular  remodelling. Signalling through the PI3K-Akt pathway increases  translation of <a href="https://en.wikipedia.org/wiki/Hypoxia-inducible_factors" title="Hypoxia-inducible factors">hypoxia-inducible  factor α</a> (HIF1α and  HIF2α) <a href="https://en.wikipedia.org/wiki/Transcription_factor" title="Transcription factor">transcription  factors</a> via mTOR. HIF  promotes gene expression of VEGF and <a href="https://en.wikipedia.org/wiki/Glycolysis" title="Glycolysis">glycolytic</a> enzymes, allowing metabolism in oxygen-depleted  environments. </p>
   
   <h3>4.2  Glucose Metabolism</h3>
   <p>In cancer cells, an increase  in Akt signalling correlates with an increase in glucose metabolism, compared  to normal cells. Cancer cells favour <a href="https://en.wikipedia.org/wiki/Glycolysis" title="Glycolysis">glycolysis</a> for energy production over mitochondrial <a href="https://en.wikipedia.org/wiki/Oxidative_phosphorylation" title="Oxidative phosphorylation">oxidative  phosphorylation</a>, even  when oxygen supply is not limited. This is known as the <a href="https://en.wikipedia.org/wiki/Warburg_effect" title="Warburg effect">Warburg effect</a>, or aerobic glycolysis. Akt affects glucose  metabolism by increasing translocation of glucose transporters <a href="https://en.wikipedia.org/wiki/GLUT1" title="GLUT1">GLUT1</a> and <a href="https://en.wikipedia.org/wiki/GLUT4" title="GLUT4">GLUT4</a> to the plasma membrane, increasing <a href="https://en.wikipedia.org/wiki/Hexokinase" title="Hexokinase">hexokinase</a> expression and phosphorylating <a href="https://en.wikipedia.org/wiki/GSK-3" title="GSK-3">GSK3</a> which stimulates <a href="https://en.wikipedia.org/wiki/Glycogen" title="Glycogen">glycogen</a> synthesis. It also activates glycolysis  enzymes indirectly, via HIF transcription factors and phosphorylation of <a href="https://en.wikipedia.org/wiki/Phosphofructokinase_2" title="Phosphofructokinase 2">phosphofructokinase-2</a> (PFK2) which activates <a href="https://en.wikipedia.org/wiki/Phosphofructokinase_1" title="Phosphofructokinase 1">phosphofructokinase-1</a> (PFK1).</p>
	   
	   
	   
	   
	   
    
			
			
<div class="media">
   <img class="mr-3" src="http://placehold.it/90x90" alt="thumbnail">
   <div class="media-body">
      <h5 class="mt-0">Media heading</h5>
      Cras sit amet nibh libero, in gravida nulla. Nulla vel metus scelerisque ante sollicitudin. Cras purus odio, vestibulum in vulputate at, tempus viverra turpis. Fusce condimentum nunc ac nisi vulputate fringilla. Donec lacinia congue felis in faucibus.
   </div>
</div>
		
 
   
</section>	
  </div><!-- col-->	
	</div><!-- row-->
	</div><!-- container-fluid-->	




<section class="bridge mybackground">
  <div class="mycontainer">
    <h1>Bridge Baclground</h1>
  </div>
</section>  

	
<footer>
    <nav>
      <div class="mycontainer">
      <ul>
        <li><a href="#jumbotron">Jumbotron</a></li>
        <li><a href="#palette">Palette</a></li>
        <li><a href="#buttons">Buttons</a></li>
        <li><a href="#typography">Typography</a></li>
        <li><a href="#lists">Lists</a></li>
        <li><a href="#media">Media</a></li>
        <li><a href="#tables">Tables</a></li>
		</ul>
    </div>
    </nav>
</footer>  


<script src="js/jquery.slim.min.js"></script>
<script src="js/popper.min.js"></script>
<script src="js/bootstrap.min.js"></script>
</body>
</html>

